Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Keros Therapeutics to Present at Upcoming Healthcare Conferences | ||
By: GlobeNewswire - 22 Nov 2022 | Back to overview list |
|
LEXINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in fireside chat presentations at the Piper Sandler 34th Annual Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference. Fireside Chat Presentation Details Piper Sandler 34th Annual Healthcare Conference
5th Annual Evercore ISI HealthCONx Conference
For each fireside chat, an archived replay will be available in the Investors section of the Keros website at https://ir.kerostx.com for 90 days following the conclusion of the event. About Keros Therapeutics, Inc. Investor Contact:
|
||
|
||
Copyright 2022 GlobeNewswire | Back to overview list |